News | News By Subject | News by Disease News By Date | Search News

Alopecia (Baldness) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News

News from Around the Web

Press Releases
Kerastem Completes Enrollment in US Phase II Hair Growth Clinical Trial     9/23/2016
Mallinckrodt (MNK) Completes Acquisition Of Stratatech Corporation, A Regenerative Medicine Company Focused On Proprietary Therapeutic Human Skin Substitute Products     9/1/2016
Mylan (MYL) Launches Generic Propecia Tablets     8/1/2016
Incyte (INCY) Reports 2016 First-Quarter Financial Results And Updates Shareholders On Key Clinical Programs     5/9/2016
Concert Pharmaceuticals, Inc. (CNCE) Unveils CTP-543 For Treatment Of Alopecia Areata     5/5/2016
Kerastem Hair Growth Clinical Trial Update     4/22/2016
Samumed Presents At The Annual Meeting Of The American Academy of Dermatology Safety And Efficacy Results From Its Phase 2 Androgenetic Alopecia (AGA) Trial     3/7/2016
Cipher Pharma (DND.TO) Announces Canadian Launch Of Actikerall     2/22/2016
Kerastem's Phase II STYLE Clinical Trial Actively Enrolling Female & Male Subjects with Early Stage Hair Loss     1/21/2016
Samumed Announces Increases In Both Hair Count And Hair Density Observed In Its Phase II Study For A Potential Treatment Of Androgenetic Alopecia (AGA)     12/4/2015
Samumed Completes Phase II Study For Its Potential Treatment Of Androgenetic Alopecia: Safety Data Show No Serious Adverse Events In Any Treated Patient     11/23/2015
Perrigo Company (PRGO) Confirms Filing for Generic Version of Men's Rogaine(R) Foam     10/13/2009
Merck & Co., Inc. (MRK) Prostate Drug Cleared of Causing Aggressive Tumors     9/12/2007
Auriga Laboratories, Inc. (ARGA.OB) Acquires Exclusive U.S. Rights to New Hair Loss Product     6/7/2007
New Web Site From Merck & Co., Inc. (MRK) Offers Men Hope With Information On Male Pattern Hair Loss     9/29/2006

//-->